These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15194863)

  • 1. The anti-migraine agent sumatriptan induces a calcium-dependent discharge in meningeal sensory neurons.
    Strassman AM; Levy D
    Neuroreport; 2004 Jun; 15(9):1409-12. PubMed ID: 15194863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dural afferent neurons innervating cranial blood vessels within the dura in rats.
    Nakamura M; Jang IS
    Brain Res; 2018 Oct; 1696():91-102. PubMed ID: 29886250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of 5-HT7 receptor reduces CGRP release in an experimental model for migraine.
    Wang X; Fang Y; Liang J; Yin Z; Miao J; Luo N
    Headache; 2010 Apr; 50(4):579-87. PubMed ID: 20236348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trigeminal ganglion elicited increases in nucleus trigeminal caudalis blood flow: a novel migraine model.
    McCall RB
    Brain Res; 1997 Nov; 775(1-2):189-92. PubMed ID: 9439842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of high homocysteine levels in migraine pain: An experimental study of the excitability of peripheral meningeal afferents in rats with hyperhomocysteinemia.
    Ermakova E; Shaidullova K; Gafurov O; Kabirova A; Nurmieva D; Sitdikova G
    Headache; 2024 May; 64(5):533-546. PubMed ID: 38650105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of calcitonin gene-related peptide secretion by a serotonergic antimigraine drug.
    Durham PL; Russo AF
    J Neurosci; 1999 May; 19(9):3423-9. PubMed ID: 10212302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triptan-induced enhancement of neuronal nitric oxide synthase in trigeminal ganglion dural afferents underlies increased responsiveness to potential migraine triggers.
    De Felice M; Ossipov MH; Wang R; Dussor G; Lai J; Meng ID; Chichorro J; Andrews JS; Rakhit S; Maddaford S; Dodick D; Porreca F
    Brain; 2010 Aug; 133(Pt 8):2475-88. PubMed ID: 20627971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sumatriptan inhibits the electrophysiological activity of ASICs in rat trigeminal ganglion neurons.
    Guo L; Zhao L; Ming P; Hong L; Liu A; Li R
    Eur J Pharmacol; 2018 Dec; 841():98-103. PubMed ID: 30336137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine action for sumatriptan?
    Read SJ; Parsons AA
    Brain Res; 2000 Jul; 870(1-2):44-53. PubMed ID: 10869500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic mechanisms of trigeminal meningeal nociception: Implications for migraine pain.
    Kilinc E; Guerrero-Toro C; Zakharov A; Vitale C; Gubert-Olive M; Koroleva K; Timonina A; Luz LL; Shelukhina I; Giniatullina R; Tore F; Safronov BV; Giniatullin R
    Neuropharmacology; 2017 Apr; 116():160-173. PubMed ID: 28025094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT1 receptor agonists, sumatriptan and CP 93,129, on dural arterial flow in the rat.
    Messlinger K; Hotta H; Pawlak M; Schmidt RF
    Eur J Pharmacol; 1997 Aug; 332(2):173-81. PubMed ID: 9286619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine.
    Wang X; Fang Y; Liang J; Yan M; Hu R; Pan X
    J Mol Neurosci; 2014; 54(2):164-70. PubMed ID: 24584680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
    J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The selectivity of MDL 74,721 in models of neurogenic versus vascular components of migraine.
    Petty MA; Elands J; Johnson MP; Linnik MD; Hamel E; Moskowitz MA; Lee WS; McCarty DR; Hibert M; Baron BM
    Eur J Pharmacol; 1997 Oct; 336(2-3):127-36. PubMed ID: 9384224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical Spreading Depression Promotes Persistent Mechanical Sensitization of Intracranial Meningeal Afferents: Implications for the Intracranial Mechanosensitivity of Migraine.
    Zhao J; Levy D
    eNeuro; 2016; 3(6):. PubMed ID: 28127585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complex actions of sumatriptan on rat dural afferents.
    Harriott AM; Scheff NN; Gold MS
    Cephalalgia; 2012 Jul; 32(10):738-49. PubMed ID: 22711897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of sumatriptan on cerebral blood flow during migraine headache: measurement by sequential SPECT used 99mTc-ECD background subtraction method].
    Ueda T; Torihara Y; Tsuneyoshi N; Ikeda Y
    No To Shinkei; 2001 Jul; 53(7):625-30. PubMed ID: 11517486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of the calcitonin gene-related peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons.
    Durham PL; Russo AF
    J Neurosci; 2003 Feb; 23(3):807-15. PubMed ID: 12574409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption.
    Kaube H; Hoskin KL; Goadsby PJ
    Br J Pharmacol; 1993 Jul; 109(3):788-92. PubMed ID: 8395298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.